Categories
Jump to navigation
Jump to search
The following categories exist on the wiki, and may or may not be unused. Also see wanted categories.
(first | last) View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Peptibody medications (1 member)
- Peptide-drug conjugates (1 member)
- Periampullary adenocarcinoma regimens (2 members)
- Peripheral T-cell lymphoma medications (34 members)
- Peripheral T-cell lymphoma medications (historic) (1 member)
- Peripheral T-cell lymphoma medications (investigational) (1 member)
- Peripheral T-cell lymphoma regimens (2 members)
- Pfizer product (2 members)
- Phenothiazines (3 members)
- Pheochromocytoma medications (4 members)
- Pheochromocytoma regimens (1 member)
- Phosphodiesterase inhibitors (1 member)
- Photosensitizers (4 members)
- Plasma cell dyscrasia medications (5 members)
- Plasma cell dyscrasia regimens (5 members)
- Plasma cell dyscrasias (12 members)
- Plasma cell leukemia medications (6 members)
- Plasma cell leukemia regimens (1 member)
- Plasma cell neoplasm medications (0 members)
- Platinum agents (7 members)
- Polycythemia vera medications (10 members)
- Polycythemia vera medications (investigational) (1 member)
- Polycythemia vera regimens (2 members)
- Post-transplant lymphoproliferative disorder medications (12 members)
- Post-transplant lymphoproliferative disorder regimens (1 member)
- Potentiating agents (3 members)
- Primary mediastinal B-cell lymphoma medications (19 members)
- Primary mediastinal B-cell lymphoma regimens (1 member)
- Profibrinolytics (1 member)
- Progestins (2 members)
- Prostate cancer medications (43 members)
- Prostate cancer medications (historic) (9 members)
- Prostate cancer medications (investigational) (4 members)
- Prostate cancer regimens (4 members)
- Proteasome inhibitors (4 members)
- Protein expression-specific medications (49 members)
- Proton pump inhibitors (4 members)
- Purine analogs (9 members)
- Purine analogues (0 members)
- Purine nucleoside phosphorylase (PNP) inhibitors (1 member)
- Pyrimidine analogs (8 members)
- Pyrimidine analogues (0 members)
- Pyruvate kinase activator (1 member)
- Pyruvate kinase deficiency medications (1 member)
- Pyruvate kinase deficiency regimens (1 member)
- RAF1 inhibitors (4 members)
- RANK ligand inhibitors (1 member)
- REMS program (22 members)
- RET inhibitors (11 members)
- RET medications (0 members)